1. Home
  2. MLAB vs BVS Comparison

MLAB vs BVS Comparison

Compare MLAB & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLAB
  • BVS
  • Stock Information
  • Founded
  • MLAB 1982
  • BVS 2011
  • Country
  • MLAB United States
  • BVS United States
  • Employees
  • MLAB N/A
  • BVS N/A
  • Industry
  • MLAB Industrial Machinery/Components
  • BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • MLAB Industrials
  • BVS Health Care
  • Exchange
  • MLAB Nasdaq
  • BVS Nasdaq
  • Market Cap
  • MLAB 524.2M
  • BVS 462.5M
  • IPO Year
  • MLAB N/A
  • BVS 2021
  • Fundamental
  • Price
  • MLAB $75.62
  • BVS $6.57
  • Analyst Decision
  • MLAB Hold
  • BVS Strong Buy
  • Analyst Count
  • MLAB 2
  • BVS 5
  • Target Price
  • MLAB $130.00
  • BVS $14.40
  • AVG Volume (30 Days)
  • MLAB 180.8K
  • BVS 468.3K
  • Earning Date
  • MLAB 08-05-2025
  • BVS 08-05-2025
  • Dividend Yield
  • MLAB 0.85%
  • BVS N/A
  • EPS Growth
  • MLAB N/A
  • BVS N/A
  • EPS
  • MLAB N/A
  • BVS N/A
  • Revenue
  • MLAB $240,978,000.00
  • BVS $567,699,000.00
  • Revenue This Year
  • MLAB $6.45
  • BVS N/A
  • Revenue Next Year
  • MLAB $5.80
  • BVS $6.11
  • P/E Ratio
  • MLAB N/A
  • BVS N/A
  • Revenue Growth
  • MLAB 11.47
  • BVS 8.60
  • 52 Week Low
  • MLAB $67.95
  • BVS $6.02
  • 52 Week High
  • MLAB $155.12
  • BVS $14.38
  • Technical
  • Relative Strength Index (RSI)
  • MLAB 35.79
  • BVS 47.42
  • Support Level
  • MLAB $67.95
  • BVS $6.81
  • Resistance Level
  • MLAB $80.93
  • BVS $6.59
  • Average True Range (ATR)
  • MLAB 4.25
  • BVS 0.29
  • MACD
  • MLAB -0.44
  • BVS -0.04
  • Stochastic Oscillator
  • MLAB 28.05
  • BVS 26.27

About MLAB Mesa Laboratories Inc.

Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.

About BVS Bioventus Inc.

Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.

Share on Social Networks: